Trends in Medical Aid in Dying in Oregon and Washington.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
02 08 2019
Historique:
entrez: 10 8 2019
pubmed: 10 8 2019
medline: 17 6 2020
Statut: epublish

Résumé

The combined 28 years of data of medical aid in dying (MAID) between Oregon (OR) and Washington (WA) are the most comprehensive in North America. No reports to date have compared MAID use in different US states. To evaluate and compare patterns of MAID use between the states with the longest-running US death with dignity programs. A retrospective observational cohort study of OR and WA patients with terminal illness who received prescriptions as part of their states' legislation allowing MAID. All published annual reports, from 1998 to 2017 in OR and from 2009 to 2017 in WA, were reviewed. A total of 3368 prescriptions were included. Number of deaths from self-administration of lethal medication vs number of prescriptions written. A combined 3368 prescriptions were written in OR and WA, with 2558 patient deaths from lethal ingestion (76.0%). Of the 2558 patients, most were male (1311 [51.3%]), older than 65 years (1851 [72.4%]), and non-Hispanic white (2426 [94.8%]). The most common underlying illnesses were cancer (1955 [76.4%]), neurologic illness (261 [10.2%]), lung disease (144 [5.6%]), and heart disease (117 [4.6%]). Loss of autonomy (2235 [87.4%]), impaired quality of life (2203 [86.1%]), and loss of dignity (1755 [68.6%]) were the most common reasons for pursuing MAID. Time between drug intake to coma ranged from 1 to 660 minutes and time from drug intake to death ranged from 1 to 6240 minutes. In the 1557 patients for whom rates of complications were reported, 1494 (96.0%) did not experience a complication (592 of 626 [94.6%] in OR and 902 of 931 [96.8%] in WA). Eight patients (<0.5%) regained consciousness after drug ingestion in OR. Annual rates per year for percentage of patients who received a prescription ingesting the prescribed medication ranged from 48% to 87%, with no significant time trend in OR (adjusted odds ratio per year, 1.01; 95% CI, 0.99-1.02; P = .59) but with an increase over time in WA (adjusted odds ratio per year, 1.13; 95% CI, 1.08-1.19; P < .001). In both OR and WA there were increases in the number of patient deaths due to MAID per 1000 deaths over time. In this study, MAID results in Oregon and Washington were similar, although MAID use measured as a percentage of patients prescribed lethal medications and then self-administering them increased only in WA. Most patients who acquired lethal prescriptions had cancer or terminal illnesses that are difficult to palliate and lead to loss of autonomy, dignity, and quality of life.

Identifiants

pubmed: 31397857
pii: 2747692
doi: 10.1001/jamanetworkopen.2019.8648
pmc: PMC6692681
doi:

Substances chimiques

Prescription Drugs 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e198648

Subventions

Organisme : NCI NIH HHS
ID : UG1 CA189974
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Arch Intern Med. 2002 Jan 28;162(2):142-52
pubmed: 11802747
BMJ. 2007 Oct 20;335(7624):806-8
pubmed: 17947786
JAMA. 2016 Jan 19;315(3):251-2
pubmed: 26784765
JAMA Oncol. 2017 Oct 1;3(10):1403-1406
pubmed: 28384683
Anaesthesia. 2019 May;74(5):630-637
pubmed: 30786320
Can J Aging. 2019 Sep;38(3):397-406
pubmed: 31046853

Auteurs

Luai Al Rabadi (L)

Oregon Health & Science University, Portland.

Michael LeBlanc (M)

SWOG Statistics and Data Management Center, Seattle, Washington.

Taylor Bucy (T)

Oregon Health & Science University, Portland.

Lee M Ellis (LM)

MD Anderson Cancer Center, Houston, Texas.

Dawn L Hershman (DL)

Columbia University, New York, New York.

Frank L Meyskens (FL)

University of California, Irvine, Chao Family Comprehensive Cancer Center, Orange.

Lynne Taylor (L)

University of Washington, Seattle.

Charles D Blanke (CD)

Oregon Health & Science University, Portland.
SWOG Group Chair's Office, Portland, Oregon.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH